A new trial reveals that weekly injections of the weight-loss drug Wegovy (semaglutide) lowered the risk of death from COVID-19 by about a third and reduced overall mortality by 19%.
Researchers are developing AI-driven smartphone applications to detect signs of depression non-invasively. One system, PupilSense, monitors pupillary reflexes to identify potential depressive episodes ...